In our study, the lupus group exhibited significantly lower autophagy expression compared with the normal control group, and ADSC/miR-20a-ADSC treatment increased autophagy activity by inhibiting the miR-20a-related Akt/mTOR pathway. The gene discussed is AKT1; the disease is systemic lupus erythematosus.